Understanding NAFLD Fibrosis Score: Normal vs Optimal Ranges
Also known as: fib-4 index, nafld fibrosis risk score, non-alcoholic fatty liver disease score
?What is NAFLD Fibrosis Score?
The NAFLD Fibrosis Score (FIB-4 Index) is a non-invasive calculation used to assess the risk of advanced liver fibrosis in patients with non-alcoholic fatty liver disease. It combines age, aspartate aminotransferase (AST), alanine aminotransferase (ALT), and platelet count to estimate fibrosis stage. A lower score suggests lower risk of advanced fibrosis.
!Why It Matters
The NAFLD Fibrosis Score helps identify individuals at higher risk of progressive liver disease and complications without requiring an invasive liver biopsy. Elevated scores may suggest significant liver fibrosis and could indicate a need for closer monitoring or specialist referral. Early identification can guide lifestyle modifications and treatment decisions to prevent cirrhosis.
Reference Ranges
| Range Type | Min | Max | Unit | Note |
|---|---|---|---|---|
| Lab Normal | — | — | — | Standard lab reference range |
| Optimal | — | 1.3 | — | Evidence-based optimal range for health |
| Longevity Target | — | 1.3 | — | Per longevity medicine research (Attia et al.) |
Lab normal ranges may vary between laboratories. Optimal and longevity targets are based on research literature and should be interpreted with your physician.
Symptoms of Imbalance
- Fatigue and weakness
- Abdominal pain or discomfort
- Swelling in the abdomen or legs
- Jaundice (yellowing of skin and eyes)
- Dark urine or pale stools
How to Improve Your Levels
- 1Achieve and maintain a healthy body weight through balanced nutrition and regular exercise
- 2Reduce refined carbohydrate and added sugar intake
- 3Limit alcohol consumption or avoid alcohol entirely
- 4Increase physical activity to at least 150 minutes of moderate exercise per week
- 5Improve insulin sensitivity through dietary changes and weight management
- 6Regular monitoring and follow-up testing as recommended by your healthcare provider
When to Test
Initial screening is recommended for individuals with metabolic risk factors (obesity, type 2 diabetes, metabolic syndrome) or abnormal liver enzyme levels. Repeat testing may be performed annually or as directed by your physician to monitor disease progression.
Related Biomarkers
Track your NAFLD Fibrosis Score with ByoMap
Upload your blood report and get personalized NAFLD Fibrosis Score ranges based on your age, sex, and ancestry — free.
Try Free — Upload Your Report